Gut hormones: implications for the treatment of obesity
- PMID: 19560488
- DOI: 10.1016/j.pharmthera.2009.06.005
Gut hormones: implications for the treatment of obesity
Abstract
Bariatric surgery is the only effective treatment for patients with morbid obesity. This is no solution to the present obesity pandemic however. Currently licensed non-surgical pharmaceuticals are of limited efficacy and alternatives are needed. Harnessing the body's own appetite-regulating signals is a desirable pharmacological strategy. The gastrointestinal tract has a prime role in sensing and signalling food intake to the brain. Gut hormones are key mediators of this information, including: peptide YY (PYY), pancreatic polypeptide (PP), glucagon-like peptide 1 (GLP-1), oxyntomodulin (OXM), ghrelin, amylin and cholecystokinin (CCK). This review summarises the latest knowledge regarding the physiological and pathophysiological role of gut hormones in regulating our food intake and how this knowledge could guide, or has guided, the development of weight-loss drugs. Up-to-date outcomes of clinical trials are evaluated and directions for the future suggested.
Similar articles
-
Gut hormones and the control of appetite.Trends Endocrinol Metab. 2004 Aug;15(6):259-63. doi: 10.1016/j.tem.2004.06.002. Trends Endocrinol Metab. 2004. PMID: 15358278 Review.
-
Obesity treatment: novel peripheral targets.Br J Clin Pharmacol. 2009 Dec;68(6):830-43. doi: 10.1111/j.1365-2125.2009.03522.x. Br J Clin Pharmacol. 2009. PMID: 20002077 Free PMC article. Review.
-
Mechanisms of disease: the role of gastrointestinal hormones in appetite and obesity.Nat Clin Pract Gastroenterol Hepatol. 2008 May;5(5):268-77. doi: 10.1038/ncpgasthep1118. Epub 2008 Apr 1. Nat Clin Pract Gastroenterol Hepatol. 2008. PMID: 18382432 Review.
-
Gut hormones and appetite control.Oral Dis. 2009 Jan;15(1):18-26. doi: 10.1111/j.1601-0825.2008.01492.x. Epub 2008 Oct 17. Oral Dis. 2009. PMID: 18939959 Review.
-
Gut and hormones and obesity.Front Horm Res. 2008;36:165-181. doi: 10.1159/000115364. Front Horm Res. 2008. PMID: 18230902 Review.
Cited by
-
Obesity pharmacotherapy: current perspectives and future directions.Curr Cardiol Rev. 2013 Feb 1;9(1):33-54. doi: 10.2174/157340313805076322. Curr Cardiol Rev. 2013. PMID: 23092275 Free PMC article. Review.
-
Childhood obesity: a role for gut microbiota?Int J Environ Res Public Health. 2014 Dec 23;12(1):162-75. doi: 10.3390/ijerph120100162. Int J Environ Res Public Health. 2014. PMID: 25546278 Free PMC article. Review.
-
Peripheral signals mediate the beneficial effects of gastric surgery in obesity.Gastroenterol Res Pract. 2015;2015:560938. doi: 10.1155/2015/560938. Epub 2015 Apr 15. Gastroenterol Res Pract. 2015. PMID: 25960740 Free PMC article. Review.
-
Hepatic leptin signalling and subdiaphragmatic vagal efferents are not required for leptin-induced increases of plasma IGF binding protein-2 (IGFBP-2) in ob/ob mice.Diabetologia. 2012 Mar;55(3):752-62. doi: 10.1007/s00125-011-2426-8. Epub 2011 Dec 28. Diabetologia. 2012. PMID: 22202803
-
Bariatric Surgery in Adolescents: To Do or Not to Do?Children (Basel). 2021 May 27;8(6):453. doi: 10.3390/children8060453. Children (Basel). 2021. PMID: 34072065 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous